10.1097/01.TP.0000045055.63901.A9
As the company explains, the program combines primary care, pharmacy and virtual options to treat obesity as a chronic conditionall in one place. To get started, patients book an initial appointment to determine candidacy
The therapy was shown to be safe, well tolerated and possibly beneficial for symptoms
Semaglutide , even at brand-name pricing of $1,300 per month, typically produces 30 to 40 pounds of weight loss over the same period
Scroll down for a full factual comparison, where the two diverge, and who each is actually relevant for
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management and chronic weight management, has been extensively studied in clinical trials